Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism.

[1]  J. Kopecka,et al.  The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance. , 2023, Cytokine & growth factor reviews.

[2]  Kyoung Song,et al.  Modulating Glycolysis to Improve Cancer Therapy , 2023, International journal of molecular sciences.

[3]  Cheng Xiao,et al.  Exosomes-mediated tumor metastasis through reshaping tumor microenvironment and distant niche. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[4]  E. Giovannetti,et al.  Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers. , 2022, Seminars in cancer biology.

[5]  Yujuan Huang,et al.  Exosome-mediated remodeling of the tumor microenvironment: From local to distant intercellular communication. , 2022, Cancer letters.

[6]  W. Chen,et al.  Renal cell carcinoma-derived exosomes deliver lncARSR to induce macrophage polarization and promote tumor progression via STAT3 pathway , 2022, International journal of biological sciences.

[7]  Z. Gil,et al.  The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment , 2022, Cells.

[8]  E. Giovannetti,et al.  The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells. , 2022, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[9]  E. Giovannetti,et al.  Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer , 2022, Diagnostics.

[10]  M. Ye,et al.  Exosome-delivered circular RNA DLGAP4 induces chemoresistance via miR-143-HK2 axis in neuroblastoma. , 2022, Cancer biomarkers : section A of Disease markers.

[11]  Xiaoyun He,et al.  Emerging Role of Cancer-Associated Fibroblasts-Derived Exosomes in Tumorigenesis , 2022, Frontiers in Immunology.

[12]  G. Di Stefano,et al.  Lactate Upregulates the Expression of DNA Repair Genes, Causing Intrinsic Resistance of Cancer Cells to Cisplatin , 2021, Pathology & Oncology Research.

[13]  K. Alfarouk,et al.  Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches , 2021, Cancers.

[14]  A. Gonçalves,et al.  Impact of cancer metabolism on therapy resistance - Clinical implications. , 2021, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[15]  M. Rafat,et al.  Extracellular vesicles: mediators of intercellular communication in tissue injury and disease , 2021, Cell communication and signaling : CCS.

[16]  I. Kerkis,et al.  Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications , 2021, Cells.

[17]  Yue Li,et al.  Hypoxia and the Tumor Microenvironment , 2021, Technology in cancer research & treatment.

[18]  B. Zhivotovsky,et al.  Receptor-Mediated Mitophagy Rescues Cancer Cells under Hypoxic Conditions , 2021, Cancers.

[19]  Fan Wang,et al.  Hypoxic exosomal HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis , 2021, Oncogene.

[20]  Xiaomei Liu,et al.  Exosomal miR‐21‐5p derived from cisplatin‐resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1 , 2021, Cell biology international.

[21]  V. LeBleu,et al.  Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer , 2021, Life Science Alliance.

[22]  G. Rice,et al.  Extracellular Vesicle Transmission of Chemoresistance to Ovarian Cancer Cells Is Associated with Hypoxia-Induced Expression of Glycolytic Pathway Proteins, and Prediction of Epithelial Ovarian Cancer Disease Recurrence , 2021, Cancers.

[23]  L. Ming,et al.  Overcoming Chemoresistance via Extracellular Vesicle Inhibition , 2021, Frontiers in Molecular Biosciences.

[24]  Hang Yu,et al.  Exosomes Derived From Macrophages Enhance Aerobic Glycolysis and Chemoresistance in Lung Cancer by Stabilizing c-Myc via the Inhibition of NEDD4L , 2021, Frontiers in Cell and Developmental Biology.

[25]  M. V. Vander Heiden,et al.  The Metabolic Landscape of RAS-Driven Cancers from biology to therapy , 2021, Nature Cancer.

[26]  Min Su,et al.  The cancer metabolic reprogramming and immune response , 2021, Molecular cancer.

[27]  Ping Zhang,et al.  CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging , 2021, International journal of nanomedicine.

[28]  Jian Zhao,et al.  Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2 , 2021, Theranostics.

[29]  M. Donadelli,et al.  Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance , 2020, Cells.

[30]  E. Giovannetti,et al.  “Open Sesame?”: Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic Cancer , 2020, Cancers.

[31]  B. Rolando,et al.  MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells. , 2020, Biochimica et biophysica acta. Molecular cell research.

[32]  Lei Zhan,et al.  Tumor-Derived Exosome-Educated Hepatic Stellate Cells Regulate Lactate Metabolism of Hypoxic Colorectal Tumor Cells via the IL-6/STAT3 Pathway to Confer Drug Resistance , 2020, OncoTargets and therapy.

[33]  W. Olejarz,et al.  Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers , 2020, International journal of molecular sciences.

[34]  Z. Heger,et al.  Drug Sequestration in Lysosomes as One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition , 2020, International journal of molecular sciences.

[35]  L. Ye,et al.  MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN/PI3K/AKT pathway. , 2020, Cellular signalling.

[36]  R. Kalluri,et al.  Exosomes as a Multicomponent Biomarker Platform in Cancer. , 2020, Trends in cancer.

[37]  Yuanting Gu,et al.  Cancer-associated fibroblasts-derived exosomes suppresses immune cell function in breast cancer via miR-92/PD-L1 pathway , 2020 .

[38]  R. Savai,et al.  Tumor-derived exosomes in the regulation of macrophage polarization , 2020, Inflammation Research.

[39]  M. Montopoli,et al.  Metabolic Plasticity in Chemotherapy Resistance , 2020, Frontiers in Oncology.

[40]  Ç. Biray Avcı,et al.  Crucial Players in Glycolysis: Cancer Progress. , 2020, Gene.

[41]  A. Mantovani,et al.  Diversity, Mechanisms, and Significance of Macrophage Plasticity. , 2020, Annual review of pathology.

[42]  Y. Ba,et al.  Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer , 2020, Molecular oncology.

[43]  L. O’Driscoll,et al.  Inhibiting extracellular vesicles formation and release: a review of EV inhibitors , 2019, Journal of extracellular vesicles.

[44]  L. Freitag,et al.  Inhibition of kras-derived exosomes downregulates immunosuppressive BACH2/GATA-3 expression via RIP-3 dependent necroptosis and miR-146/miR-210 modulation. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[45]  Samar H. Ibrahim,et al.  Integrin β1-enriched Extracellular Vesicles Mediate Monocyte Adhesion and Promote Liver Inflammation in Murine NASH. , 2019, Journal of hepatology.

[46]  E. Giovannetti,et al.  New avenues in pancreatic cancer: exploiting microRNAs as predictive biomarkers and new approaches to target aberrant metabolism , 2019, Expert review of clinical pharmacology.

[47]  Heshui Wu,et al.  Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210 , 2019, Cellular Oncology.

[48]  M. Xie,et al.  Role of hypoxia in cancer therapy by regulating the tumor microenvironment , 2019, Molecular Cancer.

[49]  F. Dilworth,et al.  The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance , 2019, Oncogene.

[50]  M. Osaki,et al.  Exosomes and Their Role in Cancer Progression. , 2019, Yonago acta medica.

[51]  D. Banerjee,et al.  Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment , 2019, Cancers.

[52]  E. Giovannetti,et al.  Pharmacogenetics of treatments for pancreatic cancer , 2019, Expert opinion on drug metabolism & toxicology.

[53]  F. Su,et al.  Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells , 2019, Nature Cell Biology.

[54]  Jianjun Chen,et al.  Hypoxia‐inducible factor‐2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin , 2019, Molecular oncology.

[55]  C. Théry,et al.  Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication , 2019, Nature Cell Biology.

[56]  F. Zhou,et al.  Prognostic Significance of Serum Lactic Acid, Lactate Dehydrogenase, and Albumin Levels in Patients with Metastatic Colorectal Cancer , 2018, BioMed research international.

[57]  M. Donadelli,et al.  Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer , 2018, Journal of Experimental & Clinical Cancer Research.

[58]  Jingru Liu,et al.  Exosomes derived from acute myeloid leukemia cells promote chemoresistance by enhancing glycolysis‐mediated vascular remodeling , 2018, Journal of cellular physiology.

[59]  C. Berkers,et al.  The Influence of Metabolism on Drug Response in Cancer , 2018, Front. Oncol..

[60]  M. Simpson,et al.  The role of cellular reactive oxygen species in cancer chemotherapy , 2018, Journal of experimental & clinical cancer research : CR.

[61]  X. Wan,et al.  Loss of exosomal miR‐148b from cancer‐associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis , 2018, Journal of cellular physiology.

[62]  A. Möller,et al.  Breast Cancer-Derived Exosomes Alter Macrophage Polarization via gp130/STAT3 Signaling , 2018, Front. Immunol..

[63]  S. Caja,et al.  Exosome-Based Cell-Cell Communication in the Tumor Microenvironment , 2018, Front. Cell Dev. Biol..

[64]  Hongyang Wang,et al.  Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer , 2018, Nature Communications.

[65]  J. Dai,et al.  LDHA promotes tumor metastasis by facilitating epithelial‑mesenchymal transition in renal cell carcinoma. , 2017, Molecular medicine reports.

[66]  Fengming Yang,et al.  Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts , 2017, Molecular Cancer.

[67]  M. Lulli,et al.  The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction , 2017, Stem cells international.

[68]  E. Giovannetti,et al.  Drug resistance in pancreatic cancer: Impact of altered energy metabolism. , 2017, Critical reviews in oncology/hematology.

[69]  Raghu Kalluri,et al.  Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in Pancreatic Cancer , 2017, Nature.

[70]  M. Henry,et al.  Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles , 2017, Scientific Reports.

[71]  Y. Takeda,et al.  MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma , 2017, Scientific Reports.

[72]  Mohammad Aslam Khan,et al.  Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK , 2017, British Journal of Cancer.

[73]  J. Kopecka,et al.  P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors , 2016, Oncotarget.

[74]  Yuan Yang,et al.  MicroRNA-210 promotes cancer angiogenesis by targeting fibroblast growth factor receptor-like 1 in hepatocellular carcinoma. , 2016, Oncology reports.

[75]  Qing‐Yu He,et al.  Cytoskeleton-centric protein transportation by exosomes transforms tumor-favorable macrophages , 2016, Oncotarget.

[76]  R. Hill,et al.  CANCER-ASSOCIATED FIBROBLAST EXOSOMES REGULATE SURVIVAL AND PROLIFERATION OF PANCREATIC CANCER CELLS , 2016, Oncogene.

[77]  Venkatareddy Nadithe,et al.  Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges , 2016, Acta pharmaceutica Sinica. B.

[78]  Shivakumar Keerthikumar,et al.  ExoCarta: A Web-Based Compendium of Exosomal Cargo. , 2016, Journal of molecular biology.

[79]  R. Soong,et al.  The Warburg effect and drug resistance , 2016, British journal of pharmacology.

[80]  M. Hasan,et al.  Cancer Metabolism and Drug Resistance , 2015, Metabolites.

[81]  B. Zetter,et al.  The Contribution of Angiogenesis to the Process of Metastasis. , 2015, Cancer journal.

[82]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[83]  Salma Khan,et al.  Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthase , 2015, OncoTargets and therapy.

[84]  S. Raimondo,et al.  Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism , 2015, Cell Communication and Signaling.

[85]  C. Porta,et al.  The role of the cell–cell interactions in cancer progression , 2015, Journal of cellular and molecular medicine.

[86]  E. Gazzano,et al.  Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma , 2014, Oncotarget.

[87]  D. Mukhopadhyay,et al.  GAIP Interacting Protein C-Terminus Regulates Autophagy and Exosome Biogenesis of Pancreatic Cancer through Metabolic Pathways , 2014, PloS one.

[88]  F. Bianchini,et al.  The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy , 2014, Cell cycle.

[89]  E. Giovannetti,et al.  Molecular Mechanisms Underlying the Role of MicroRNAs in the Chemoresistance of Pancreatic Cancer , 2014, BioMed research international.

[90]  Pieter Vader,et al.  Extracellular vesicles: emerging targets for cancer therapy. , 2014, Trends in molecular medicine.

[91]  S. McKeown,et al.  Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. , 2014, The British journal of radiology.

[92]  N. Wall,et al.  Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant , 2014, Journal of extracellular vesicles.

[93]  Triantafyllos Stylianopoulos,et al.  Combining two strategies to improve perfusion and drug delivery in solid tumors , 2013, Proceedings of the National Academy of Sciences.

[94]  Y. Wang,et al.  MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain , 2013, Gene Therapy.

[95]  W. Ding,et al.  Intercellular Communication by Exosome-Derived microRNAs in Cancer , 2013, International journal of molecular sciences.

[96]  Wenchuan Wu,et al.  Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells , 2013, Tumor Biology.

[97]  E. Giovannetti,et al.  Molecular targets of gemcitabine action: rationale for development of novel drugs and drug combinations. , 2012, Current pharmaceutical design.

[98]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[99]  A. Sapino,et al.  HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast , 2012, BMC Cancer.

[100]  F. Khuri,et al.  Tyrosine Phosphorylation of Lactate Dehydrogenase A Is Important for NADH/NAD+ Redox Homeostasis in Cancer Cells , 2011, Molecular and Cellular Biology.

[101]  P. Oefner,et al.  Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. , 2009, Neuro-oncology.

[102]  Fabio Martelli,et al.  MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3* , 2008, Journal of Biological Chemistry.

[103]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[104]  G. Peters,et al.  Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines , 2003, British Journal of Cancer.

[105]  S. Kanwal,et al.  Cancer Chemoresistance; Recent Challenges and Future Considerations. , 2023, Cancer treatment and research.

[106]  Di Liu,et al.  miR-449a Suppresses LDHA-Mediated Glycolysis to Enhance the Sensitivity of Non-Small Cell Lung Cancer Cells to Ionizing Radiation. , 2018, Oncology research.

[107]  W. Rathmell,et al.  Metabolic Alterations in Cancer and Their Potential as Therapeutic Targets. , 2017, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[108]  M. Miyazaki,et al.  Cobalt Chloride Induces Expression and Function of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Renal Proximal Tubular Epithelial Cell Line HK-2. , 2017, Biological & pharmaceutical bulletin.

[109]  T. Whiteside.  Tumor-Derived Exosomes and Their Role in Cancer Progression. , 2016, Advances in clinical chemistry.

[110]  John R. Mackey,et al.  Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial. , 2014, Journal of the National Cancer Institute.

[111]  Adam P Dicker,et al.  Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer. , 2009, Gastroenterology.